fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Natco Pharma Ltd

Natco Pharma Ltd

Updated on October 15, 2020

Stock/Share Code - NATCOPHARM

Natco Pharma Ltd is engaged in the business of pharmaceuticals which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations.

Below is the details of NATCOPHARM Natco Pharma Ltd

Market Cap₹13,686 Cr.
Current Price ₹929.9 as on 21 Oct 20
52 Week High / Low Price₹898 / ₹402.55
Face Value₹2
Stock P/E30.18
Book Value₹212.53
Dividend Yield0.90 %
ROCE14.85 %
ROE12.77 %
Sales Growth (3yrs)-2.94 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 21.60%
Cons:

Natco Pharma Ltd Price Chart

Natco Pharma Ltd Price Chart

Natco Pharma Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹806.2 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹439.6 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹426.35 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Natco Pharma 30.18 ₹13,686.05 Cr. 0.90 ₹126.7 Cr. -14.22 14.53 532.20 14.85

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Natco Pharma Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -408540729516522532416465458448420532
YOY Sales Growth %-8.96%-17.83%34.45%24.69%27.91%-1.55%-42.89%-9.89%-12.39%-15.83%0.91%14.53%
Expenses -283254353291292322266269321321302360
Material Cost %26.05%11.23%16.30%15.53%17.17%20.40%14.60%15.36%25.80%20.95%27.06%32.77%
Employee Cost %17.26%13.96%14.54%16.52%17.06%16.73%18.47%18.94%21.39%20.86%18.28%16.91%
Operating Profit125286376225231210150196137127119173
OPM %31%53%52%44%44%40%36%42%30%28%28%32%
Other Income51121364024312034313920
Interest443347566543
Depreciation161718182020212222253028
Profit before tax110276376240247206154188144127124162
Tax %21%21%21%21%22%22%20%22%15%19%18%22%
Net Profit87217296189193162123148122104101127
EPS in Rs4.9812.3316.0510.2210.478.786.738.116.725.705.556.96
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -2653073484365586227161,0591,9582,0911,9861,7901,858
Sales Growth %15.88%16.16%13.31%25.07%28.04%11.56%14.98%48.03%84.86%6.81%-5.02%-9.87%
Expenses -1972222573244024364907781,2661,1631,1701,2121,303
Material Cost %33.82%31.69%28.99%30.82%29.57%24.22%23.86%24.20%29.25%18.58%17.07%22.18%
Manufacturing Cost %12.43%12.44%14.40%14.02%14.59%15.07%12.66%14.83%7.74%8.43%9.03%0.00%
Employee Cost %14.06%14.20%15.35%15.41%15.31%15.14%16.24%16.24%11.86%14.93%17.13%19.89%
Other Cost %14.07%13.73%14.92%14.18%12.61%15.58%15.72%18.23%15.80%13.67%15.66%25.65%
Operating Profit688692111156187226281692928816578555
OPM %26%28%26%26%28%30%32%26%35%44%41%32%30%
Other Income1141102161131339130124123
Interest15151423253430221815192118
Depreciation101414152027425054668098104
Profit before tax53616483112141154222634888847583556
Tax %20%22%19%25%30%22%1%20%22%21%21%19%
Net Profit4348526278110153176495698667474454
EPS in Rs3.013.323.643.894.856.499.009.8928.3637.8436.5526.0824.93
Dividend Payout %8%12%11%15%16%15%11%12%24%22%17%26%

Compounded Sales Growth

  • 10 Years:: 19.27%
  • 5 Years:: 20.13%
  • 3 Years:: -2.94%
  • TTM:: -4.01%

Compounded Profit Growth

  • 10 Years:: 25.39%
  • 5 Years:: 23.90%
  • 3 Years:: -1.39%
  • TTM:: -27.58%

Return on Equity

  • 10 Years:: 29.59%
  • 5 Years:: 10.75%
  • 3 Years:: 1.65%
  • 1 Year:: 38.95%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -282828313133333535373636
Equity Capital28.0428.1528.1531.1531.3733.0733.2334.8034.9036.9036.5036.40
Reserves2282733194365067008461,3021,6653,0883,5273,833
Borrowings126119220259336237309110221173384314
Other Liabilities -122112129163184206207396427438408463
Trade Payables747173849699115270251245202234
Advance from Customers1063111152024141819
Other liability items38365469879271102161174188229
Total Liabilities5045336968891,0571,1761,3951,8432,3473,7364,3564,647
Fixed Assets -2012332543024715295737068291,0151,2151,574
Gross Block2733193544176066917839761,1511,4001,678
Accumulated Depreciation7286100115135162210270322384463
CWIP4740761647893101212336480638518
Investments5979717578891319495150244191
Other Assets -1971812953484314655908311,0872,0912,2592,363
Inventories65669397128162198352337426508524
Trade receivables57557093126116189256469606492537
Cash Equivalents2043134887402517226354
Loans n Advances5657394849565012719680387981
Other asset items-1062761201241465660841181,168
Total Assets5045336968891,0571,1761,3951,8432,3473,7364,3564,647

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -5069326870172125190330476699422
Profit from operations749798118158198217303734962860628
Receivables-122-17-23-3311-72-76-237-149121-54
Inventory-10-7-28-5-32-34-37-14315-89-82-16
Payables15-6161120420151-19-6-4335
Loans Advances-7-111-22-1312586-1-1-2-71
Other WC items00-3111-81411-87-40-36215
Working capital changes-14-12-48-28-666-72-68-282-28114-101
Direct taxes-10-16-18-23-22-32-20-45-122-204-175-105
Cash from Investing Activity --67-54-83-129-123-131-148-248-291-1,131-645-165
Fixed assets purchased-54-38-93-129-102-96-107-153-277-424-452-355
Fixed assets sold000000210181822
Investments purchased0-0-2-1-1-0000-48-91-64
Investments sold0000123-401600120
Subsidy received000000000000
Interest received110233028105289
Dividends received000000040000
Invest in subsidiaries000-5-3-12-230000-5
Loans to subsidiaries0000-20-27-220-3-5-400
Acquisition of companies00000000-14-7-40
Other investing items-13-17113-2-1-0-62-21-674-12928
Cash from Financing Activity -17-31806229-4123151-46652-52-261
Proceeds from shares0006801090334089600
Proceeds from borrowings43751436012131115012502120
Repayment of borrowings-10-82-43-27-47-130-43-130-14-480-80
Interest paid fin-15-14-15-28-31-32-29-26-15-15-18-20
Dividends paid-0-11-7-11-14-19-20-26-141-181-111-154
Financial liabilities00000000000-2
Other financing items000000000-0-135-5
Net Cash Flow0-16281-240-193-6-31-4

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %18%19%17%16%18%19%18%18%39%34%24%15%
Debtor Days79657478836896888710690109
Inventory Turnover1.751.721.541.691.791.321.171.091.811.170.850.77

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Natco Pharma Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.